Acadian Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,736
| Closed | -$78K | – | 1743 |
|
|
2023
Q2 | $78K | Sell |
8,736
-155,935
| -95% | -$1.39M | ﹤0.01% | 1453 |
|
|
2023
Q1 | $1.29M | Sell |
164,671
-343,816
| -68% | -$2.7M | 0.01% | 816 |
|
|
2022
Q4 | $3.44M | Buy |
508,487
+503,446
| +9,987% | +$3.4M | 0.02% | 543 |
|
|
2022
Q3 | $73K | Buy |
+5,041
| New | +$73K | ﹤0.01% | 1432 |
|
|
2021
Q3 | – | Sell |
-6,002
| Closed | -$144K | – | 1856 |
|
|
2021
Q2 | $144K | Buy |
+6,002
| New | +$144K | ﹤0.01% | 1537 |
|